Recent Finacing
Recent Raise
Tacalyx is a Berlin-based biotech company that discovers and develops cancer therapies targeting tumour associated carbohydrate antigens (TACAs).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Tacalyx.